Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
Nambu H, Takada S, Maekawa S, Matsumoto J, Kakutani N, Furihata T, Shirakawa R, Katayama T, Nakajima T, Yamanashi K, Obata Y, Nakano I, Tsuda M, Saito A, Fukushima A, Yokota T, Nio-Kobayashi J, Yasui H, Higashikawa K, Kuge Y, Anzai T, Sabe H, Kinugawa S.
Nambu H, et al. Among authors: yasui h.
Cardiovasc Res. 2021 Feb 22;117(3):805-819. doi: 10.1093/cvr/cvaa127.
Cardiovasc Res. 2021.
PMID: 32402072